,Generic Drug Name,Generic Manufacturer,Brand Name,Approval Date,
1.,DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS 100 MG,ROXANE LABORATORIES INC,PRISTIQ EXTENDED-RELEASE TABLETS 100 MG,,
2.,DESVENLAFAXINE SUCCINATE EXTENDED-RELEASE TABLETS50 MG,ROXANE LABORATORIES INC,PRISTIQ EXTENDED-RELEASE TABLETS50 MG,,
3.,BIMATOPROST OPHTHALMIC SOLUTION0.03%,APOTEX INC.,LATISSE OPHTHALMIC SOLUTION,12/1/2014,
4.,METHOCARBAMOL INJECTION USP100 MG/ML; PACKAGED IN1000 MG/10 ML SINGLE-DOSE VIALS,MYLAN INSTITUTIONAL,ROBAXIN INJECTABLE,12/5/2014,
5.,ESTRADIOL TRANSDERMAL SYSTEM USP 0.025 MG/DAY 0.0375 MG/DAY 0.05 MG/DAY 0.075 MG/DAY AND 0.1 MG/DAY (TWICE-WEEKLY),MYLAN TECHNOLOGIES INC.,VIVELLE-DOT TRANSDERMAL SYSTEM,12/19/2014,
6.,FENTANYL TRANSDERMAL SYSTEM 37.5 MG/HR 62.5 MG/HR 87.5 MG/HR,MYLAN TECHNOLOGIES INC.,DURAGESIC TDS - SP 04P-0069/CP1,12/29/2014,
